To evaluate the translational potential of TSG-6 inhibition, we employed a commercially available anti-TSG-6 antibody and conducted survival experiments in the pancreatic tumor model (Fig. 5a). The gene discussed is TNFAIP6; the disease is pancreatic neoplasm.